Drug Trial Radar · NCT03809481
Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban
Last checked: Nov 20, 2026Latest source record: Dec 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
7
Actual
Start
May 16, 2019
Primary completion
Jun 10, 2022
Study completion Jun 10, 2022
Sponsor
- Lead sponsor
- Aspen Global IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Jan 18, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 weeks, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Treatment of Subjects with Acute HIT (HITSOVA study)
Conditions
- Heparin-induced Thrombocytopenia
Interventions
Danaparoid SodiumDrug
inhibits thrombin generation by indirect anti-Xa inhibition and direct inhibition of factor IX activation
ArgatrobanDrug
Synthetic direct thrombin inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite Efficacy ResponseTime frame: Day 44
Locations
35 sites in 9 countries. Site status is shown where the registry gives one.
Shands University of Florida
Gainesville, Florida
University of Minnesota Medical Center
Minneapolis, Minnesota
Duke University Medical Center
Durham, North Carolina
The Ohio State University Wexner Medical Center
Columbus, Ohio
The University of Texas MD Anderson Cancer Center
Houston, Texas
University Clinical Centre of the Republic of Srpska, Clinic for cardiology
Banja Luka, Bosnia and Herzegovina
University Clinical Centre of the Republic of Srpska, Lung Clinic
Banja Luka, Bosnia and Herzegovina
Clinical Center University of Sarajevo, Clinic for Heart, Blood Vessels and Rheumatic Diseases
Sarajevo, Bosnia and Herzegovina
Clinical Center University of Sarajevo, Clinic for Lung Diseases
Sarajevo, Bosnia and Herzegovina
Clinical Center of the Republic of Srpska, Medical Intesnive Care Unit
Banja Luka, Republika Srpska, Bosnia and Herzegovina
Jewish General Hospital
Montreal, Canada
CHU St Etienne; Avenue Albert Raimond
Saint-Priest-en-Jarez, Auvergne-Rhône-Alpes, France
DIJON University Hospital
Dijon, Burgundy, France
Centre Hospitalier Universitaire Amiens Picardie
Amiens, Somme, France
University Hospital Greifswald Dpt. of Hematology
Greifswald, Germany
Zentrum für Klinische Transfusionsmedizin
Tübingen, Germany
Vivantes Klinikum im Friedrichhain Hämophiliezentrum, Gerinnungssprechstunde Landsberger Allee 49
Berlin, Berlin-Brandenburg, Germany
Universitätsklinikum Gießen und Marburg GmbH, Klinik für Herz-, Kinderherz- und Gefäßchirurgie Standort Gießen
Giesen, Lower Saxony, Germany
Städtisches Klinkum Dresden
Dresden, Saxony, Germany
Universitatstklinikum Halle (Saale), Medizinische Klinik III
Halle, Saxony-Anhalt, Germany
Instituto Scientifico San Raffaele- Servizio Coagulazione e Centro Trombosi
Milan, Italy
Azienda Ospedaliero Universitaria S.Orsola-Malpighi - UO Angiologia e Malattie della Coagulazione
Bologna, Emilia-Romagna, Italy
AOU Careggi, SOD Malattie Aterotrombotiche
Florence, Florence, Italy
ASST Papa Giovanni XIII, Servizio di Immunoematologia e Medicina Trasfusionale
Bergamo, Lombardy, Italy
Centrum Medyczne HCP Sp. z o.o. Szpital im. Św. Jana Pawła II
Poznan, Poland
Wojewódzki Szpital Zespolony im. L. Rydygiera
Torun, Poland
First City Hospital N.A. E.E. Volosevich
Arkhangelsk, Russia
Moscow City Hospital 67
Moscow, Russia
Oncology Center
Omsk, Russia
Regional Hospital after N.N Burdenko
Penza, Russia
Clinical Hospital № 122 N. A. L.G. Sokolov
Saint Petersburg, Russia
Clinical Centre of Serbia, Clinic for Emergency Internal Medicine
Belgrade, Serbia
Clinical centre of Serbia, Clinic for Pulmonology
Belgrade, Serbia
Instiute of Cardiovascular Diseases "Dedinje"
Belgrade, Serbia
The Institute for Pulmonary Disease of Vojvodina, Pulmonary thromboembolism department
Novi Sad, Sremska Kamenica, Serbia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.